Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tarceva in First Relapse Glioblastoma Multiforme
NCT00337883Phase 2Completed
- Sponsor
- Genentech
- Start
- Jul 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of erlotinib in glioblastoma (GBM), sponsored by Genentech. Started Jul 2003; status: completed.
02
Drugs
erlotinib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT00337883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00337883.